Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-01-04
2011-01-04
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S078000, C549S079000, C549S080000
Reexamination Certificate
active
07863319
ABSTRACT:
A compound comprisingor a pharmaceutically acceptable salt or a prodrug thereof,having the groups described in detail herein is disclosed.Also disclosed herein are compounds comprisingor derivatives thereof, or pharmaceutically acceptable salts, tetrazoles, or prodrugs of compounds of the structure or derivatives thereof, said derivatives being described in detail herein.Also disclosed herein are methods of treating diseases or conditions, including glaucoma and elevated intraocular pressure. Compositions and methods of manufacturing medicaments related thereto are also disclosed.
REFERENCES:
patent: 4055602 (1977-10-01), Nelson
patent: 4119727 (1978-10-01), Buendia et al.
patent: 4166452 (1979-09-01), Generales, Jr.
patent: 4256108 (1981-03-01), Theeuwes
patent: 4265874 (1981-05-01), Bonsen et al.
patent: 4994274 (1991-02-01), Chan et al.
patent: 5028624 (1991-07-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
patent: 5446041 (1995-08-01), Chan et al.
patent: 6124344 (2000-09-01), Burk
patent: 7183310 (2007-02-01), Donde et al.
patent: 2626888 (1977-04-01), None
patent: 2719244 (1977-11-01), None
patent: 0283151 (1988-09-01), None
patent: 1601994 (1978-04-01), None
patent: 53135955 (1978-11-01), None
patent: WO/90/02553 (1990-03-01), None
patent: WO/94/06432 (1994-03-01), None
patent: WO 95/11682 (1995-05-01), None
patent: WO 95/26729 (1995-10-01), None
patent: WO 99/25358 (1999-05-01), None
Bito, L.Z.Biological Protection with Prostaglandins, Cohen, M.M., ed., Boca Raton, Fla, CRC Press Inc., 1985, pp. 231-252.
Bito, L.Z.,Applied Pharmacology in the Medical Treatment of GlaucomasDrance, S.M. and Neufeld, A.H. eds., New York, Grune & Stratton, 1984, pp. 477-505.
Bito, L.Z.,Arch. Ophthalmol. 105, 1036 (1987).
Francis A. Carey, Organic Chemistry, New York: McGraw-Hill Book Company 1987, p. 63.
Nilsson et. al.,Invest. Ophthalmol. Vis. Sci. (suppl), 284 (1987).
Remington's Pharmaceutical Science's, Mack Publishing Company, Easton, Pa., 16th Edition, 1980.
Siebold et al.,Esterified Prostaglandin Shows ‘Potent’ Promise, Ocular Surgery News, vol. 1, No. 3 (Feb. 1989); pp. 3, 59.
Burk Robert M.
Donde Yariv
Garst Michael E.
Allergan Inc.
Anderson Rebecca L
Ene Doina G.
Forrestal Kevin J.
Nolan Jason M
LandOfFree
Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2659799